跳至主要内容
临床试验/JPRN-UMIN000013537
JPRN-UMIN000013537已完成未知

A phase II clinical trial of carbon-ion radiotherapy using 2 fractions for hepatocellular carcinoma smaller than and equal to 30mm - A phase II clinical trial of carbon-ion radiotherapy using 2 fractions for hepatocellular carcinoma smaller than and equal to 30mm

SAGA HIMAT foundation0 个研究点目标入组 35 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patient recieved any other therapies for hepatocellular carcinoma within 4 weeks from the first day of the carbon-ion radiotherapy. 2) The alimentary tract is included in and adjacent to the planning target volume. 3) Patient with ascites. 4) Patient with hepatic encephalopathy. 5) Patient with sever paraesophageal varix or portal hypertention. 6) Patient with intractable esophageal or gastric varix. 7) Patients with any other active malignancies. 8) Patients with active and intractable infection at the same position where carbon-ion radiotherapy is planned.

研究者

发起方
SAGA HIMAT foundation

相似试验